PENN Capital Management »

Nurix Therapeutics shares owned by PENN Capital Management

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by PENN Capital Management from 13F filings

Historical chart of PENN Capital Management investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by PENN Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by PENN Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $800k 33k 24.26

More positions owned by PENN Capital Management

Ouster Com New (OUST)
Acm Resh Com Cl A (ACMR)
Mirum Pharmaceuticals (MIRM)
Ligand Pharmaceuticals Com New (LGND)
Tg Therapeutics (TGTX)
Rxo Common Stock (RXO)
Legence Corp Cl A (LGN)
Seaworld Entertainment (PRKS)
Penn National Gaming (PENN)
Wolfspeed Common Stock (WOLF)
Compass Cl A (COMP)
Banc Of California (BANC)
Select Water Solutions Cl A Com (WTTR)
Agilysys (AGYS)
Constellium Se Cl A Shs (CSTM)

View all positions for PENN Capital Management

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Vestal Point Capital
Deep Track Capital
FMR
State Street Corporation
Morgan Stanley
Baker Bros. Advisors
Vanguard Capital Management
General Atlantic
Perceptive Advisors
T. Rowe Price Associates
Geode Capital Management
Rubric Capital Management
Pictet Asset Management Holding SA

View all funds holding Nurix Therapeutics